KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingTax ProvisionsTax Rate
Others
Ratios

Omega Healthcare Investors (OHI) Revenue (2016 - 2025)

Historic Revenue for Omega Healthcare Investors (OHI) over the last 17 years, with Q4 2025 value amounting to $319.2 million.

  • Omega Healthcare Investors' Revenue rose 1428.44% to $319.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.2 billion, marking a year-over-year increase of 1319.29%. This contributed to the annual value of $1.2 billion for FY2025, which is 1319.29% up from last year.
  • Latest data reveals that Omega Healthcare Investors reported Revenue of $319.2 million as of Q4 2025, which was up 1428.44% from $311.6 million recorded in Q3 2025.
  • In the past 5 years, Omega Healthcare Investors' Revenue ranged from a high of $319.2 million in Q4 2025 and a low of $8.7 million during Q3 2021
  • Its 5-year average for Revenue is $243.0 million, with a median of $250.1 million in 2021.
  • Its Revenue has fluctuated over the past 5 years, first plummeted by 9269.99% in 2021, then skyrocketed by 265206.9% in 2022.
  • Over the past 5 years, Omega Healthcare Investors' Revenue (Quarter) stood at $249.9 million in 2021, then tumbled by 42.05% to $144.8 million in 2022, then surged by 65.22% to $239.3 million in 2023, then grew by 16.71% to $279.3 million in 2024, then grew by 14.28% to $319.2 million in 2025.
  • Its last three reported values are $319.2 million in Q4 2025, $311.6 million for Q3 2025, and $282.5 million during Q2 2025.